이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Sam Chun Dang Pharm 관리
관리 기준 확인 0/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Dae-In Yoon
최고 경영자
n/a
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | no data |
| CEO 소유권 | 7.1% |
| 경영진 평균 재임 기간 | 데이터 없음 |
| 이사회 평균 재임 기간 | 데이터 없음 |
최근 관리 업데이트
Recent updates
Subdued Growth No Barrier To Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) With Shares Advancing 44%
Jun 19
Is Sam Chun Dang Pharm (KOSDAQ:000250) A Risky Investment?
Jun 09Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking
Mar 21Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly
Feb 26Investors Who Bought Sam Chun Dang Pharm (KOSDAQ:000250) Shares Five Years Ago Are Now Up 644%
Feb 09Could The Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Ownership Structure Tell Us Something Useful?
Jan 05
Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly
Dec 01CEO
Dae-In Yoon (74 yo)
no data
테뉴어
Dae-In Yoon serves as the Chief Executive Officer and Chairman of Sam Chun Dang Pharmacy. Dae-In Yoon serves as Chief Executive Officer and Chairperson of Sam Chun Dang Pharm Co. Ltd. Dae-In Yoon serves as...